甲胺使用与喘发展和不良结果的关联:系统性审查和元分析
Rui Rao1, Juan Mei1, Hudie Chen2
1Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Medicine
|October 28, 2024
概括
在患有喘的2型糖尿病患者中使用甲福明显示了喘发病率降低的趋势,但仅显著降低了住院的风险. 需要更多的研究来证实甲胺.
科学领域:
- 肺病学和内分泌学.
- 药理干预治疗慢性疾病的方法
背景情况:
- 喘和2型糖尿病是常见的慢性疾病,具有重大的全球影响.
- 作为一种主要的2型糖尿病药物,甲胺正在研究喘管理中的潜在益处.
- 喘和糖尿病的并发症需要了解甲胺在减轻喘不良后果中的作用.
研究的目的:
- 综合分析甲胺在降低糖尿病喘患者不良后果方面的疗效.
- 评估甲胺对喘恶化,急诊,住院和新的喘发展的影响.
主要方法:
- 在PubMed,Embase和CENTRAL数据库的系统文献搜索 (2023年9月之前).
- 包括观察性研究,其中成人参与者被诊断患有喘和2型糖尿病.
- 甲福明使用者与非使用者之间的喘恶化发生率和严重程度的比较,分析使用R.
主要成果:
- 对7项涉及1,176,398名患者的研究的分析表明,在使用甲福明时,降低了新的喘发病率的趋势并不显著.
- 使用甲胺并没有显著减少喘恶化,急诊或全身皮质类固醇处方.
- 在甲胺使用者中,观察到与喘相关的住院住院风险显著降低.
结论:
- 目前的证据并没有明确支持甲胺在降低糖尿病患者大多数喘相关不良事件的有效性.
- 需要进一步的长期研究和更多的数据来确定甲胺在控制喘并发症中的作用.
- 甲胺显示出潜在的潜力,需要继续调查其在呼吸系统疾病干预中的应用.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.1K
05:10Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
176
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
176
01:24Antiasthma Drugs: Methylxanthines
199
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
199
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:19Antiasthma Drugs: Leukotriene Modifiers
246
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
246
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K